Related Experiment Video
Updated: Mar 23, 2026

Uncontrolled Hemorrhagic Shock Modeled via Liver Laceration in Mice with Real Time Hemodynamic Monitoring
Published on: May 21, 2017
Hemostatic balance in patients with liver cirrhosis: Report of a consensus conference
Insights
Cirrhosis causes complex hemostatic alterations, rebalancing the blood clotting system. This consensus outlines optimal management for bleeding and thrombosis risks in cirrhotic patients.
Area of Science:
- Hepatology
- Hematology
- Internal Medicine
Background:
- Patients with cirrhosis exhibit altered hemostasis due to reduced pro-coagulant and anti-coagulant factors, leading to a rebalanced system.
- Understanding these hemostatic perturbations is crucial for managing bleeding and thrombotic risks.
Framework:
- A consensus conference was convened by the Italian Association of the Study of the Liver (AISF) and the Italian Society of Internal Medicine (SIMI).
- The process involved a literature review by experts, a formal consensus meeting, and grading of statements by evidence quality and recommendation strength.
- An independent jury approved the final consensus statements.
Implementation:
- The consensus evaluates the strengths and weaknesses of current laboratory tests for assessing bleeding and thrombotic risk in cirrhosis.
- It details the pathophysiology of hemostatic changes in liver cirrhosis.
- The statements provide guidance on the optimal management of bleeding and thrombosis.
Implications:
- This consensus offers a framework for improved diagnosis and management of hemostatic disorders in cirrhotic patients.
- It aims to enhance clinical decision-making regarding bleeding and thrombosis in liver cirrhosis.
- The findings support evidence-based practice for managing hemostatic balance in this patient population.
Abstract:
Patients with cirrhosis present with hemostatic alterations secondary to reduced availability of pro-coagulant and anti-coagulant factors. The net effect of these changes is a rebalanced hemostatic system. The Italian Association of the Study of the Liver (AISF) and the Italian Society of Internal Medicine (SIMI) promoted a consensus conference on the hemostatic balance in patients with cirrhosis. The consensus process started with the review of the literature by a scientific board of experts and ended with a formal consensus meeting in Rome in December 2014. The statements were graded according to quality of evidence and strength of recommendations, and approved by an independent jury. The statements presented here highlight strengths and weaknesses of current laboratory tests to assess bleeding and thrombotic risk in cirrhotic patients, the pathophysiology of hemostatic perturbations in this condition, and outline the optimal management of bleeding and thrombosis in patients with liver cirrhosis.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...

